Home
About
Overview
Sharing Data
ORCID
Help
History (51)
Exercise metabolism and adaptation in skeletal muscle.
High-Throughput Assay for Profiling the Substrate Specificity of Rab GTPase-Activating Proteins.
Sustainment of diverse evidence-informed practices disseminated in the Veterans Health Administration (VHA): initial development and piloting of a pragmatic survey tool.
Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.
Pioglitazone Use and Risk of Bladder Cancer.
See All 51 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pioglitazone Use and Risk of Bladder Cancer.
Singh S, Suchard MA. Pioglitazone Use and Risk of Bladder Cancer. JAMA. 2015 Dec 15; 314(23):2567-8.
View in:
PubMed
subject areas
Diabetes Mellitus, Type 2
Female
Humans
Hypoglycemic Agents
Male
Pancreatic Neoplasms
Prostatic Neoplasms
Thiazolidinediones
Urinary Bladder Neoplasms
authors with profiles
Sonal Singh MD, MPH